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Abstract 
According to the 2005 histological classification of odontogenic neoplasms by the World Health Organization, 
ameloblastoma is a benign, locally invasive epithelial odontogenic tumor of putative enamel organ origin. There are 
four distinct subgroups in which this neoplasm can be gathered: the solid/multicystic type, the unicystic type, the 
desmoplastic and the peripheral type. Peripheral ameloblastoma is believed to be the rarest subgroup, making up for 
2 to 10% of all ameloblastomas. From its first description by Kuru in 1911 to date, less than 200 cases of PA have 
been described in literature. PAs commonly affect the mandible, in the maxilla the most common location is the soft 
palatal tissue of the tuberosity area. The present report discusses a rare case of PA aroused in the gingiva of upper 
jaw in a 64-year-old woman. The treatment of the lesion and its immunohistochemical phenotype are described. A 
review of the literature is also performed, focusing on the epidemiological and pathological aspects of the lesions 
and their implications on the therapy.
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Introduction
According to the 2005 histological classification of 
odontogenic neoplasms by the World Health Organiza-
tion (WHO) (1-3), ameloblastoma is a benign, locally 
invasive epithelial odontogenic tumor of putative ena-
mel organ origin. Account for about one percent of all 
oral tumors and about 11% of odontogenic tumors (4). 
There are four distinct subgroups in which this neoplasm 
can be gathered: the solid/multicystic type, the unicystic 
type, the desmoplastic and the peripheral type (1). Peri-
pheral ameloblastoma (PA) is believed to be the rarest 
subgroup, making up for 2 to 10% of all ameloblasto-
mas (2,5). It was first described by Kuru in 1911 (6). 
To date, less than 200 cases of PA have been described 
in literature (7, 8). PAs commonly affect the mandible 
(3,9-12), especially the lingual gingiva in the premolar 
region (2,13), followed by the anterior region (2,3). In 
the maxilla, the most common location is the soft palatal 
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male-predominant and to occur at a higher age than its 
intraosseous counterpart (M/F 1,14:1; 35 years) (14,15). 
The most frequent onset site is the mandibular premolar 
region, followed by the anterior mandibular region and 
by the tuber maxillae. Roughly 7 cases of PA out of 10 
occur in the lower jaw (2). Review of the English lan-
guage literature between 1987 to 1999, disclosed only 
13 in the maxillary area (12). In their review of 160 PA 
cases published in English or in Japanese language (74 
cases)  Philipsen et al. reported 46 cases (29.1%) in the 
maxilla and only 23 cases (8 in not-japanese patients) in-
volving the upper gingiva (2). However other few cases 
were reported in literature (Table 1).
The actual histogenesis of PA is still controversial. Two 
main theories about the cellular origin of PA have been 
developed. Some tumors, being located completely wi-
thin the gingival connective tissue with no contact to the 
surface epithelium or divided from the surface epithelium 
by a connectival band, are suggestive to derive from the 
“Serre’s pearls”, that is to say from the extraosseous ce-
llular residuals of the dental lamina (2,3,8). On the other 
hand, many other cases of PA present themselves in a 
very close relationship with the surface epithelium. Ide 
et al. described a case of PA in which multiple sectioning 
failed to detect any epithelial nests in the submucosa, in 
fact describing an in-situ lesion that seems to provide 
a remarkable evidence that at least a share of cases of 
PA take origin from the surface epithelial layer (16,17). 
tissue of the tuberosity area (2,5). The present report dis-
cusses a rare case of PA aroused in the gingiva of upper 
jaw.
Case Report
A 64-year-old Caucasian woman referred to our Unit 
with a 2-month history of a tender lesion on the vesti-
bular gingiva of the posterior left maxillary region. No 
pain or bleeding associated to the lesion was reported. 
The patient reported previous history of surgically trea-
ted breast cancer. She affirmed a smoking history of 5 
cigarettes per day in the last 40 years and occasional 
alcohol consumption. At the clinical examination, there 
was a sessile mass of about 1 cm distally to the second 
molar. The mass was dark red and ulcerated (Fig. 1). The 
consistence was tender; there were no bleeding or pain 
on palpation. No other lesions in the oral cavity and in 
the oropharynx, or abnormalities in the head and neck 
district were reported. CT scan, MRI scan and an inci-
sional biopsy were subsequently performed. Imaging 
described a 19mm x 15mm x 22 mm mass arising from 
the posterior alveolar edge of the left maxillary bone, 
protruding into the vestibule with no signs of bone ero-
sion, or muscular infiltration with regard to the internal 
and external left pterygoid muscles. No lymphadenopa-
thies were described. The incisional biopsy assessed the 
presence of a plexiform structured epithelial neoplasm, 
with basaloid and squamous components; immunohisto-
chemistry showed strong positivity for anti-cytokeratin 
antibodies MNF-116, a mild positivity for podoplanin 
and negativity for calretinin. The overall pattern was 
suggestive for peripheral ameloblastoma. The patient 
subsequently underwent the resection of the lesion with 
surrounding bone tissue and the extraction of the second 
molar using an intraoral access; a Bichat flap was used 
for closure. The final pathologic diagnosis was periphe-
ral ameloblastoma, with a plexiform pattern consisting 
of islands and strands of odontogenic epithelium within 
a fibrous stroma (Fig. 1). The tumor resulted to be stron-
gly positive for CK14 (Fig. 1) and diffusely positive for 
CK19 (Fig. 1) and CKAE1-3 (Fig. 1). Ki-67 labeling in-
dex was 2%. Moreover, expression of podoplanin was 
evident in peripheral cuboidal neoplastic cells of tumor 
nests, whereas it was expressed slightly in central stella-
te reticulum-like cells (Fig. 1). No complications were 
observed during recovery. The patient was dismissed 
three days after surgery. No recurrence of disease was 
observed after 2-year follow-up.
Discussion
Epidemiological data extrapolated from the literature as-
sess the maximum incidence of PA in the sixth decade of 
life, with a male/female ratio amounting to 1,9:1, with 
an average age of presentation of 52,9 years in males 
and 50,6 years in females (10). PA seems to be more 
Fig. 1. a) Macroscopic aspect of the lesion; b) Hematoxylin-eosin, 
40X. The tumor shows a plexiform pattern. It consists of island and 
strands of odontogenic epithelium within a fibrous stroma. The basal 
cells of these stands are columnar, hyperchromatic and lined up in a 
palisaded fashion; c) 40X. Tumor positivity for CK14; d) 40X. Tumor 
positivity for CK19; e) 40X. Tumor positivity for CKAE1-3; f) 40X. 
Expression of podoplanin is evident in peripheral cuboidal neoplas-
tic cells of tumor nests and it is expressed slightly in central stellate 
reticulum-like cells.
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Multifocal growth of PA has also been described (18). 
The macroscopic presentation of PA is usually that of a 
solid mass, either sessile or pedunculated, which may 
be in color from pink to dark red (8). The surface of 
the mass may be smooth, granular or warty (8). Minute 
cystic spaces filled with fluid may be found when the 
mass is cut. Dimensions rarely exceed 2 cm in diameter 
(8). The microscopic aspect of PA is characterized by 
ameloblastic growth within a squamous epithelial layer, 
being the tumor composed by nests of loosely connected 
cells (19). Another interesting issue about the histolo-
gy of PA lies in its similarity with basal cell carcinoma 
(BCC). Some Authors tend to consider the two lesions 
as the same entity, arguing that they share some pecu-
liar aspects such as the proliferation of basal cells and 
its island-like arrangement with an important presence 
of fibrous stroma (20). However, if immunohistochemi-
cal analysis is considered, the patterns of positivity for 
cytokeratins is different between PA and BCC, rather su-
ggesting a greater similarity between PA and its intraos-
seous counterpart and thus an origin of the lesion from 
odontogenic epithelial remnants and not from the basal 
cell layer of the gingival epithelium (3). PA is positive 
for cytokeratin 19, whereas the opposite is true for BCC 
(8). A correct distinction among PA and BCC is of pi-
votal importance, since the treatment of the two lesions 
greatly differs in the required radicality. The debate on 
the histogenesis, as assessed previously, is still open and 
challenging (19,21,22). In literature there are four repor-
ted cases of a Peripheral desmoplastic ameloblastoma 
(23-25). 
Apart from BCC, differential diagnosis for PA must con-
sider a range of mucosal and submucosal lesions that 
may occur in the oral cavity, such as pyogenic granulo-
ma, peripheral ossifying fibroma, peripheral giant cell 
granuloma, odontogenic gingival epithelial hamartoma. 
Reactions to ill-fitting dentures and post-inflammatory 
lesions like fissuratum epulis and inflammatory papi-
llary hyperplasia also have to be considered. PA showing 
continuity with surface epithelium should as well be di-
fferentiated from epithelial neoplasms such as squamous 
cell carcinoma or verrucous carcinoma (26,27).
As far as imaging is concerned, in most cases there is no 
evidence of bony infiltration. A cortical bone erosion or 
a local depression, described as cupping or sauceriza-
tion, may occasionally be described (2,3,5,10,28). The 
lack of infiltration may be explained through the existen-
ce of a fibrous barrier surrounding the lesion generated 
by the gingiva and the periosteum. This aspect of the 
biological behavior of PA makes this pathology greatly 
Author Year Nation Sex Age Region Treatment Follow-up
Batsakis & 
McClatchey(33) 
1983 US maxillary surgery
Schaberg et al. (34) 1983 US male 54 posterior maxilla surgery
Patrikiou et al. (35) 1983 Greece female 76 upper alveolar crest surgery no evidence of recurrence 8 
months later.
Hernandez et al. (36) 1992 Spain male 54 ?? surgery
Baden et al.(32) 1993 US male 82 the maxillary left tube-
rosity
surgery Two recurrence over a 5-year 
period (once as squamous cell 
carcinoma and once as undiffer-
entiated carcinoma).
Califano et al.(37) 1996 Italy 23 12-month no recidive (malig-
nant aspect)
Tajima et al. (27) 2001 Japan male 40 Left maxilla alveolar surgery
Buchner et al. (10) 2005 USA female unknow edentulous 1st molar 
region
Buchner et al. (10) 2005 USA female 85 edentulous 2nd molar 
region
Buchner et al. (10) 2005 USA male 84 palatal gingival, canine to 
1st molar region
Yamamoto et al.(38) 2005 Japan female 71 maxillary canine region Radical surgery 15-year no recidive
Martelli-Junior et al. 
(39)
2005 Brazil male 20 the lingual gingiva of the 
right posterior region
LeCorn et al. (40) 2006 US male 61 Anterior region maxilla surgery
Gomes et al.(41) 2007 Brazil female 79 right posterior alveolar 
mucosa
surgery 9 months – no recidive
Vanoven et al. (8) 2008 US male 73 Left maxilla alveolar surgery
Ide et al.(16) 2009 Japan female 73 12-22 surgery an in situ lesion of peripheral ameloblastoma
Nonaka et al(5) 2013 Brazil female 54 15-16 Surgery 9 years – no recidive
Bertossi et al. 2013 Italy Female 64 27 surgery 2 years – no recidive
Table 1. Reported cases of peripheral ameloblastoma of upper gingiva.
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12. Manor Y, Mardinger O, Katz J, Taicher S, Hirshberg A. Peripheral 
odontogenic tumours--differential diagnosis in gingival lesions. Int J 
Oral Maxillofac Surg. 2004;33:268-73.
13. el-Mofty SK, Gerard NO, Farish SE, Rodu B. Peripheral amelo-
blastoma: a clinical and histologic study of 11 cases. J Oral Maxillofac 
Surg. 1991;49:970-4; discussion 4-5.
14. Reichart PA, Jundt G. [Benign epithelial odontogenic tumors]. Pa-
thologe. 2008;29:175-6, 8-88.
15. Mendenhall WM, Werning JW, Fernandes R, Malyapa RS, Mend-
enhall NP. Ameloblastoma. Am J Clin Oncol. 2007;30:645-8.
16. Ide F, Mishima K, Miyazaki Y, Saito I, Kusama K. Peripheral ame-
loblastoma in-situ: an evidential fact of surface epithelium origin. Oral 
Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:763-7.
17. Ide F. Peripheral ameloblastoma of the buccal mucosa. Oral Surg 
Oral Med Oral Pathol Oral Radiol Endod. 2010;109:653-4; author re-
ply 4-5.
18. Gardner DG. Peripheral ameloblastoma: a study of 21 cases, in-
cluding 5 reported as basal cell carcinoma of the gingiva. Cancer. 
1977;39:1625-33.
19. Tsuneki M, Maruyama S, Yamazaki M, Cheng J, Saku T. Podo-
planin expression profiles characteristic of odontogenic tumor-specific 
tissue architectures. Pathol Res Pract. 2012;208:140-6.
20. Simpson HE. Basal-cell carcinoma and peripheral ameloblastoma. 
Oral Surg Oral Med Oral Pathol. 1974;38:233-40.
21. Thosaporn W, Iamaroon A, Pongsiriwet S, Ng KH. A comparative 
study of epithelial cell proliferation between the odontogenic kerato-
cyst, orthokeratinized odontogenic cyst, dentigerous cyst, and amelo-
blastoma. Oral Dis. 2004;10:22-6.
22. Gonzalez-Alva P, Tanaka A, Oku Y, Miyazaki Y, Okamoto E, Fuji-
nami M, et al. Enhanced expression of podoplanin in ameloblastomas. 
J Oral Pathol Med. 2010;39:103-9.
23. Bologna-Molina R, Mosqueda-Taylor A, de Almeida-Oslei P, 
Toral-Rizo V, Martinez-Mata G. Peripheral desmoplastic ameloblas-
toma: histopathological and immunohistochemical profile of a case. 
Med Oral Patol Oral Cir Bucal. 2010;15:e846-9.
24. Curran AE, Byerly PD. Peripheral desmoplastic ameloblastoma: 
report of a rare case. J Oral Maxillofac Surg. 2008;66:820-5.
25. Smullin SE, Faquin W, Susarla SM, Kaban LB. Peripheral desmo-
plastic ameloblastoma: report of a case and literature review. Oral Surg 
Oral Med Oral Pathol Oral Radiol Endod. 2008;105:37-40.
26. Lopez-Jornet P, Bermejo-Fenoll A. Peripheral ameloblasto-
ma of the gingiva: the importance of diagnosis. J Clin Periodontol. 
2005;32:12-5.
27. Tajima Y, Kuroda-Kawasaki M, Ohno J, Yi J, Kusama K, Tanaka 
H, et al. Peripheral ameloblastoma with potentially malignant features: 
report of a case with special regard to its keratin profile. J Oral Pathol 
Med. 2001;30:494-8.
28. Redman RS, Keegan BP, Spector CJ, Patterson RH. Peripheral 
ameloblastoma with unusual mitotic activity and conflicting evidence 
regarding histogenesis. J Oral Maxillofac Surg. 1994;52:192-7.
29. Siar CH, Lau SH, Ng KH. Ameloblastoma of the jaws: a retrospec-
tive analysis of 340 cases in a Malaysian population. J Oral Maxillofac 
Surg. 2012;70:608-15.
30. Koukourakis GV, Miliadou A, Sotiropoulou-Lontou A. Amelo-
blastoma, a rare benign odontogenic tumour: an interesting tumour 
review targeting the role of radiation therapy. Clin Transl Oncol. 
2011;13:793-7.
31. Wettan HL, Patella PA, Freedman PD. Peripheral ameloblastoma: 
review of the literature and report of recurrence as severe dysplasia. J 
Oral Maxillofac Surg. 2001;59:811-5.
32. Baden E, Doyle JL, Petriella V. Malignant transformation of periphe-
ral ameloblastoma. Oral Surg Oral Med Oral Pathol. 1993;75:214-9.
33. Batsakis JG, McClatchey KD. Ameloblastoma of the maxilla and 
peripheral ameloblastomas. Ann Otol Rhinol Laryngol. 1983;92:532.
34. Schaberg SJ, Antimarino RF, Pierce GL, Crawford BE. Peripheral 
ameloblastoma. Report of a case. Int J Oral Surg. 1983;12:344-7.
35. Patrikiou A, Papanicolaou S, Stylogianni E, Sotiriadou S. Periphe-
ral ameloblastoma. Case report and review of the literature. Int J Oral 
Surg. 1983;12:51-5.
different from intraosseous ameloblastoma, which con-
versely is characterized by a high degree of bony erosion 
and marrow infiltration, with great implications onto the 
treatment plan (15). 
The treatment of choice for PA is the surgical excision 
with proper disease-free margins (9,29). No extensive 
radical treatment is usually required. Although the role 
of radiation therapy in the treatment of ameloblastomas 
has been investigated (30), the low occurrence and the 
peculiar non-aggressive behavior of PA seem to dis-
courage this treatment option. The biological evolutional 
behavior of PA is characterized by a frequent tendency 
to recurrence [16%-20%], however inferior to the recu-
rrence rate of intraosseous ameloblastoma (2). It is not 
clear whether the recurrence rate is an actual feature of 
the lesion or is rather to be due to incomplete removal of 
the primary mass. Literature describes a few cases of PA 
with malignant characteristics (31). These cases presen-
ted either with primary and metastatic differentiated be-
nign-appearing lesions or with dedifferentiated lesions. 
Long-term follow-up is therefore mandatory (32).
In conclusion, considering the descriptions of PAs now 
available in the literature, these lesions seem to be re-
latively benign pathologies that however should not be 
considered harmless at all. Some aspects of PA such as, 
for instance, its histogenesis and its relationships with 
similar lesions, still require more studies in order to be 
fully understood.
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